Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hui-Chu Lang

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Applied Health Economics and Health Policy|September 9, 2008
The lifetime cost of hepatocellular carcinoma : a claims data analysis from a medical centre in TaiwanHui-Chu Lang, Jaw-Ching Wu, Sang-Hue Yen, et al.
International Journal of Rheumatic Diseases|February 19, 2016
The impact of introducing biologics to patients with rheumatoid arthritis in Taiwan: a population-based trend studyHui-Chu Lang, Hou-Ching Lee, Shinn-Shing Lee, et al.
Hepatology International|November 15, 2018
Risks of hepatocellular carcinoma and cirrhosis-associated complications in patients with rheumatoid arthritis: a 10-year population-based cohort study in TaiwanChing-Sheng Hsu, Hui-Chu Lang, Kuang-Yung Huang, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2013
Validating and improving the reliability of the EORTC qlq-c30 using a multidimensional Rasch modelChing-Lin Shih, Chien-Hung Chen, Ching-Fan Sheu, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|July 9, 2021
Cost-effectiveness analysis of olaparib and niraparib as maintenance therapy for women with recurrent platinum-sensitive ovarian cancerJohn Hang Leung, Hui-Chu Lang, Shyh-Yau Wang, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|March 17, 2021
Cost-utility analysis of stereotactic body radiotherapy plus cetuximab in previously irradiated recurrent squamous cell carcinoma of the head and neckHenry Wc Leung, Hui-Chu Lang, Shyh-Yau Wang, et al.
Health Policy (Amsterdam, Netherlands)|December 23, 2018
Real-world cost-effectiveness of drug-eluting stents vs. bare-metal stents for coronary heart disease-A five-year follow-up studyHao-Min Cheng, Ling-Jan Chiou, Tzu-Ching Chen, et al.
Acta Cardiologica Sinica|January 25, 2017
Comparison of Clinical Outcomes in Patients Undergoing Coronary Intervention with Drug-Eluting Stents or Bare-Metal Stents: A Nationwide Population StudyShih-Hsien Sung, Tzu-Ching Chen, Hao-Min Cheng, et al.
Clinical and Experimental Rheumatology|September 6, 2014
Disease activity affects all domains of quality of life in patients with rheumatoid arthritis and is modified by disease durationYing-Ming Chiu, Mei-Shu Lai, Hsiao-Yi Lin, et al.
Journal of Medical Internet Research|August 2, 2022
Factors Associated With the Utilization of Outpatient Virtual Clinics: Retrospective Observational Study Using Multilevel AnalysisYun-Hsuan Tzeng, Wei-Hsian Yin, Kuan-Chia Lin, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Applied Health Economics and Health Policy|September 9, 2008
The lifetime cost of hepatocellular carcinoma : a claims data analysis from a medical centre in TaiwanHui-Chu Lang, Jaw-Ching Wu, Sang-Hue Yen, et al.
International Journal of Rheumatic Diseases|February 19, 2016
The impact of introducing biologics to patients with rheumatoid arthritis in Taiwan: a population-based trend studyHui-Chu Lang, Hou-Ching Lee, Shinn-Shing Lee, et al.
Hepatology International|November 15, 2018
Risks of hepatocellular carcinoma and cirrhosis-associated complications in patients with rheumatoid arthritis: a 10-year population-based cohort study in TaiwanChing-Sheng Hsu, Hui-Chu Lang, Kuang-Yung Huang, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2013
Validating and improving the reliability of the EORTC qlq-c30 using a multidimensional Rasch modelChing-Lin Shih, Chien-Hung Chen, Ching-Fan Sheu, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|July 9, 2021
Cost-effectiveness analysis of olaparib and niraparib as maintenance therapy for women with recurrent platinum-sensitive ovarian cancerJohn Hang Leung, Hui-Chu Lang, Shyh-Yau Wang, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|March 17, 2021
Cost-utility analysis of stereotactic body radiotherapy plus cetuximab in previously irradiated recurrent squamous cell carcinoma of the head and neckHenry Wc Leung, Hui-Chu Lang, Shyh-Yau Wang, et al.
Health Policy (Amsterdam, Netherlands)|December 23, 2018
Real-world cost-effectiveness of drug-eluting stents vs. bare-metal stents for coronary heart disease-A five-year follow-up studyHao-Min Cheng, Ling-Jan Chiou, Tzu-Ching Chen, et al.
Acta Cardiologica Sinica|January 25, 2017
Comparison of Clinical Outcomes in Patients Undergoing Coronary Intervention with Drug-Eluting Stents or Bare-Metal Stents: A Nationwide Population StudyShih-Hsien Sung, Tzu-Ching Chen, Hao-Min Cheng, et al.
Clinical and Experimental Rheumatology|September 6, 2014
Disease activity affects all domains of quality of life in patients with rheumatoid arthritis and is modified by disease durationYing-Ming Chiu, Mei-Shu Lai, Hsiao-Yi Lin, et al.
Journal of Medical Internet Research|August 2, 2022
Factors Associated With the Utilization of Outpatient Virtual Clinics: Retrospective Observational Study Using Multilevel AnalysisYun-Hsuan Tzeng, Wei-Hsian Yin, Kuan-Chia Lin, et al.
Pageof 4